In the present study, we aimed to assess the immunoexpressions of PD-L1 and EZH2 in ECs and evaluate their associations with key clinicopathological parameters, including patients’ age, tumour grade and stage, depth of myometrial invasion, histological subtype, and survival outcomes. Here, CD274 is linked to neoplasm.